Navigation Links
FDA approves drug for rare liver disease

Hereditary tyrosinemia type 1( HT-1) is a genetic metabolic disorder that causes progressive liver failure and liver cancer in young children. It's a very rare disease.// It is not among the metabolic diseases that all newborns are tested for at birth, so often infants die undiagnosed. This is an absolutely fatal disease until now.

Children born with such a very rare but very lethal liver disease have won the first drug that promises to help them live years longer. The drug, named Orfadin, amazingly is a failed weed killer that Swedish scientists discovered could fight a disease called hereditary tyrosinemia.

"This is a real breakthrough drug," said Dr. Marlene Haffner of the U.S. Food and Drug Administration. She said scientists once referred to the drug as "Lazarene, because these kids were so sick and then they were well."

For babies who are diagnosed, the only treatment is a special low-protein diet. Orfadin may significantly improve those dismal statistics. It works by blocking formation of the liver-destroying toxins. The drug's cost depends on the dose, which varies with the child's size: $12,000 a year for an infant, up to $60,000 a year for an older child.
'"/>




Page: 1

Related medicine news :

1. FDA approves new device to treat womens bleeding disorder
2. FDA approves surgical gel
3. FDA approves first pocket-sized EKG machine
4. FDA approves Watson Pharmaceuticals Oxytrol patch
5. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
6. Madras High Court Disapproves of Comparative Advertisements
7. FDA approves Phase 0 trial which tests experimental drugs on humans
8. FDA approves CLARINEX-D 12 HOUR for seasonal allergic rhinitis
9. Study disapproves a new Asthma inhaler
10. GMC Disapproves Internet Doctor
11. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: FDA approves drug for rare liver disease

(Date:7/13/2014)... 2014 The federal court overseeing thousands ... filed against Johnson & Johnson’s Ethicon, Inc. is preparing ... expected to get underway next month. According to an ... Court, Southern District of West Virginia on July 9, ... 7, 2014 at 3:00 p.m. July selection is slated ...
(Date:7/13/2014)... Max International has recently ... be the featured guest at its Charity Exhibition and ... Attendees will learn about Max’s health products and ... basketball games and perform in a 3 point shoot-out. ... and energy-boosting supplements , has recently announced former NBA ...
(Date:7/13/2014)... 2014 Fadhits.com is popular among worldwide ... are extremely beautiful. Recently, the company has announced its ... 2014. What’s more, all these outfits are available at ... , Additionally, the supplier is now offering similar discounts ... dresses, it has many other designs for sale, including ...
(Date:7/13/2014)... imaging device developed at Cedars-Sinai can provide early ... brain and are a classic sign of Alzheimer,s ... a clinical trial in Australia. , The researchers ... oral presentation at the Alzheimer,s Association International Conference ... by conference organizers to participate in a "breaking ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 According to the ... is a step by step guide on what to do ... easily and quickly. Vkool writes in its review that readers ... to eat to revitalize their kidney health. Vkool also informs ... help people reverse their damaged kidney functions naturally. The book ...
Breaking Medicine News(10 mins):Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 3Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 4Health News:Fadhits.com Announces a Special Offer on Elegant Quinceanera Dresses 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 3Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 2Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 3
... E-Book Offers Options During National Infertility Awareness ... Blossom Consulting, LLC, a,Chicago-based infertility consultancy with ... their free E-Book, Financing Your Infertility,Treatment, available ... E-Book addresses the financial,aspects of infertility, and ...
... cardio health , , TUESDAY, Nov. 6 (HealthDay News) -- ... practitioners at risk for heart disease in as little ... individuals followed the maintenance phase of the diet -- ... and other markers for heart disease, experts report. ...
... 6, 2007 People who have a mother with Alzheimers disease ... those individuals whose fathers are afflicted, according to a new study ... The study is published in this weeks online edition ... the first to compare brain metabolism among cognitively normal people who ...
... This release is also availabe in Spanish . ... of Granada have devised a new technique to determine the ... was carried out by Dr. Pedro Manuel Garamendi Gonzlez ... Inmaculada Alemn Aguilera . This is of special interest in the ...
... -- Each year, pharmaceutical companies invest millions of dollars to ... because of side effects found only during human clinical trials. ... organ transplants continues to increase. In the past 10 years, ... by a University of Missouri-Columbia physics researcher might present new ...
... seven cities, ... including Largo, Fla., ORLANDO, Fla., Nov. ... techniques supports the widespread use of the American,Heart Association,s new 2005 ... AHA,s Scientific Sessions on November 4 in,Orlando. Lead author, Tom P. ...
Cached Medicine News:Health News:Lotus Blossom Consulting Announces E-Book on Infertility Treatment Financing 2Health News:Atkins Diet Can Raise Heart Risks 2Health News:Atkins Diet Can Raise Heart Risks 3Health News:Atkins Diet Can Raise Heart Risks 4Health News:A maternal link to Alzheimer's disease 2Health News:A maternal link to Alzheimer's disease 3Health News:New technique to determine the age of immigrant minors through ribs and teeth 2Health News:MU research team makes progress toward 'printing' organs 2Health News:MU research team makes progress toward 'printing' organs 3Health News:Study Released at AHA Shows Survival to Hospital Discharge After Cardiac Arrest Doubles With Improved CPR and Impedance Threshold Device 2
(Date:7/11/2014)... July 11, 2014 Patient engagement has ... consequently, organizations are turning to an assortment of ... As part of this evolving approach to patient ... communicate and engage patients throughout their experiences with ... empowerment. By mapping the patient journey and employing ...
(Date:7/11/2014)... 11, 2014 Research and Markets  has ... Market 2014-2018" report to their offering. ... needle is a hollow needle commonly used with a ... to extract fluids from it. A hypodermic needle is ... substances that cannot be ingested. Hypodermic needles are broadly ...
(Date:7/11/2014)... July 11, 2014 Research and Markets ... the "Immunoprotein Diagnostic Testing Market - Forecasts ... CAGR of 6% and is expected to be ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... testing has been segmented according to immunoprotein types ...
Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2
... 21, 2011 ClinStar, LLC , an established ... Europe to the pharmaceutical and biotechnology industry, announced today ... Marcus Evans 6th Annual Clinical Research in Emerging ... (Logo: http://photos.prnewswire.com/prnh/20110719/SF36975LOGO ) The ...
... On the 1-year anniversary of Congress approving the District ... Patients, Cooperative (DCPC), a District-based non-profit organization and Safe ... Safe Access, will hold a press conference on Wednesday, ... John A. Wilson Building, 1350 Pennsylvania Ave. NW.   ...
Cached Medicine Technology:ClinStar to Present on Conducting Clinical Trials in Russia 2DC Patients' Cooperative to Announce Operations Hiatus Until City Shows Leadership 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: